Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other Accumulated Expenses (2019 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Other Accumulated Expenses for 7 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 12.61% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, down 12.61% year-over-year, with the annual reading at $5.0 million for FY2025, 12.61% down from the prior year.
  • Other Accumulated Expenses hit $5.0 million in Q4 2025 for Harmony Biosciences Holdings, up from $1.8 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $25.1 million in Q1 2024 to a low of $262000.0 in Q1 2021.
  • Historically, Other Accumulated Expenses has averaged $6.1 million across 5 years, with a median of $4.1 million in 2022.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 1147.33% in 2022 and later crashed 84.47% in 2025.
  • Year by year, Other Accumulated Expenses stood at $301000.0 in 2021, then skyrocketed by 439.53% to $1.6 million in 2022, then surged by 380.91% to $7.8 million in 2023, then fell by 27.38% to $5.7 million in 2024, then fell by 12.61% to $5.0 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for HRMY at $5.0 million in Q4 2025, $1.8 million in Q3 2025, and $3.1 million in Q2 2025.